Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Chutes & Ladders—Former Legend CEO lands at K2

Chutes & Ladders—Former Legend CEO lands at K2

August 13, 2026Posted inBiotechnology

Just weeks after Legend Biotech announced the departure of its CEO, Ying Huang, K2 Therapeutics has announced that Wang will now lead the startup, which was founded in 2024 with a $50 million seed round from MPM BioImpact.

Post navigation

Previous Post
one-step-catalyst-synthesis-converts-carbon-dioxide-into-useful-methane One-step catalyst synthesis converts carbon dioxide into useful methane
Next Post
Phage contingency loci let viruses hedge against bacterial defenses phage-contingency-loci-let-viruses-hedge-against-bacterial-defenses

Recent Posts

  • Digital Twins Accelerate Oxide Transistor Optimization, Overcoming Performance–Reliability Trade-offs
  • Pilot Study Examines Personal Care Use, Social Media Engagement Among NJ Students
  • KAIST develops semiconductor neuron that harnesses noise to selectively process signals
  • Imagining natural and extra robotic thumbs together strengthens kinesthetic sensorimotor networks
  • PARP1 Drives Neuropathic Pain Through GPX4-Dependent Ferroptosis in Injured Mice’s Sensory Neurons

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top